Free Webex Call
The Global Infectious Disease Testing Market was valued at USD16753.39 million in 2020 and is anticipated to reach USD27712.09 million in 2026 by registering a growing CAGR of around 8.27%. The Global Infectious Disease Testing Market is driven by rising population having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of the market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of the market over the next few years. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Infectious Disease Testing Market is segmented based on product and service, technology, disease, end-user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share in 2020 and is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.
Major players operating in the Global Infectious Disease Testing Market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., Meridian Bioscience Inc., Quidel Corporation, Siemens AG, Thermo Fisher Scientific Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid Inc., Qiagen N.V., OraSure Technologies, Inc. and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022-2026
Objective of the Study:
- To analyze the historical growth in the market size of the Global Infectious Disease Testing Market from 2016 to 2020.
- To estimate and forecast the market size of the Global Infectious Disease Testing Market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast the Global Infectious Disease Testing Market based on product and service, technology, disease, end-user, company and regional distribution.
- To identify dominant region or segment in the Global Infectious Disease Testing Market.
- To identify drivers and challenges for the Global Infectious Disease Testing Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Infectious Disease Testing Market.
- To conduct pricing analysis for the Global Infectious Disease Testing Market.
- To identify and analyze the profile of leading players operating in the Global Infectious Disease Testing Market.
- To identify key sustainable strategies adopted by market players in the Global Infectious Disease Testing Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of hospitals/clinics across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The publisher analyzed the hospitals/clinics and presence of all major players across the globe.
The publisher calculated the market size of the Global Infectious Disease Testing Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Infectious disease testing hospitals/clinics, laboratories and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to infectious disease testing
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.
Report Scope:
In this report, the Global Infectious Disease Testing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Global Infectious Disease Testing Market, By Product and Service:
- Assays, Kits, & Reagents
- Instruments
- Services & Software
Global Infectious Disease Testing Market, By Technology:
- Molecular Diagnostics
- Immunoassay
- Microbiology
- Others
Global Infectious Disease Testing Market, By Disease:
- Hepatitis
- Human Papillomavirus (HPV)
- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Hospital-Acquired Infections (HAIs)
- Others
Global Infectious Disease Testing Market, By End-User:
- Hospital/Clinical Laboratories
- Diagnostic Reference Laboratories
- Academic/Research Institutes
- Others
Global Infectious Disease Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
- Company Profiles: Detailed analysis of the major companies present in the Global Infectious Disease Testing Market.
Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.
Frequently Asked Questions about the Global Infectious Disease Testing Market
What is the estimated value of the Global Infectious Disease Testing Market?
What is the growth rate of the Global Infectious Disease Testing Market?
What is the forecasted size of the Global Infectious Disease Testing Market?
Who are the key companies in the Global Infectious Disease Testing Market?
| Report Attribute | Details |
|---|---|
| Published | June 2021 |
| Forecast Period | 2016 - 2026 |
| Estimated Market Value ( USD | $ 12846.51 Million |
| Forecasted Market Value ( USD | $ 27712.09 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
Table of Contents
1. Product Overview2. Research Methodology
3. Impact of COVID-19 on Global Infectious Disease Testing Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Customer Satisfaction Analysis
5.3. Unmet Needs/Challenges
6. Global Infectious Disease Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
6.2.2. By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others)
6.2.3. By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others)
6.2.4. By End User (Hospital/Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map
7. North America Infectious Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Service
7.2.2. By Technology
7.2.3. By Disease
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Infectious Disease Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product and Service
7.3.1.2.2. By Technology
7.3.1.2.3. By Disease
7.3.1.2.4. By End User
7.3.2. Canada Infectious Disease Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product and Service
7.3.2.2.2. By Technology
7.3.2.2.3. By Disease
7.3.2.2.4. By End User
7.3.3. Mexico Infectious Disease Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product and Service
7.3.3.2.2. By Technology
7.3.3.2.3. By Disease
7.3.3.2.4. By End User
8. Europe Infectious Disease Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Service
8.2.2. By Technology
8.2.3. By Disease
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Infectious Disease Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product and Service
8.3.1.2.2. By Technology
8.3.1.2.3. By Disease
8.3.1.2.4. By End User
8.3.2. United Kingdom Infectious Disease Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product and Service
8.3.2.2.2. By Technology
8.3.2.2.3. By Disease
8.3.2.2.4. By End User
8.3.3. France Infectious Disease Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product and Service
8.3.3.2.2. By Technology
8.3.3.2.3. By Disease
8.3.3.2.4. By End Use
8.3.4. Italy Infectious Disease Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product and Service
8.3.4.2.2. By Technology
8.3.4.2.3. By Disease
8.3.4.2.4. By End User
8.3.5. Spain Infectious Disease Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product and Service
8.3.5.2.2. By Technology
8.3.5.2.3. By Disease
8.3.5.2.4. By End User
9. Asia-Pacific Infectious Disease Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Service
9.2.2. By Technology
9.2.3. By Disease
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Infectious Disease Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product and Service
9.3.1.2.2. By Technology
9.3.1.2.3. By Disease
9.3.1.2.4. By End User
9.3.2. Japan Infectious Disease Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product and Service
9.3.2.2.2. By Technology
9.3.2.2.3. By Disease
9.3.2.2.4. By End User
9.3.3. India Infectious Disease Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product and Service
9.3.3.2.2. By Technology
9.3.3.2.3. By Disease
9.3.3.2.4. By End User
9.3.4. South Korea Infectious Disease Testing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product and Service
9.3.4.2.2. By Technology
9.3.4.2.3. By Disease
9.3.4.2.4. By End User
9.3.5. Australia Infectious Disease Testing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product and Service
9.3.5.2.2. By Technology
9.3.5.2.3. By Disease
9.3.5.2.4. By End User
10. South America Infectious Disease Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Service
10.2.2. By Technology
10.2.3. By Disease
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Infectious Disease Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product and Service
10.3.1.2.2. By Technology
10.3.1.2.3. By Disease
10.3.1.2.4. By End User
10.3.2. Argentina Infectious Disease Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product and Service
10.3.2.2.2. By Technology
10.3.2.2.3. By Disease
10.3.2.2.4. By End User
10.3.3. Colombia Infectious Disease Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product and Service
10.3.3.2.2. By Technology
10.3.3.2.3. By Disease
10.3.3.2.4. By End Use
11. Middle East and Africa Infectious Disease Testing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product and Service
11.2.2. By Technology
11.2.3. By Disease
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Infectious Disease Testing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product and Service
11.3.1.2.2. By Technology
11.3.1.2.3. By Disease
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product and Service
11.3.2.2.2. By Technology
11.3.2.2.3. By Disease
11.3.2.2.4. By End User
11.3.3. UAE Infectious Disease Testing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product and Service
11.3.3.2.2. By Technology
11.3.3.2.3. By Disease
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Abbott Laboratories
14.2. Becton, Dickinson and Company
14.3. bioMérieux SA
14.4. Bio-Rad Laboratories Inc.
14.5. Danaher Corporation
14.6. DiaSorin S.p.A.
14.7. Meridian Bioscience Inc.
14.8. Quidel Corporation
14.9. Siemens AG
14.10. Thermo Fisher Scientific Inc.
14.11. Johnson and Johnson
14.12. F. Hoffmann-La Roche Ltd
14.13. Cepheid Inc.
14.14. Qiagen N.V.
14.15. OraSure Technologies, Inc.
15. Strategic Recommendations
16. About the Publisher & DisclaimerList of Figures
Figure 1: Global Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 3: Global Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 4: Global Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 5: Global Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 6: Global Infectious Disease Testing Market Share, By Company, 2020
Figure 7: Global Infectious Disease Testing Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Infectious Disease Testing Product Market Map, By Value, 2016-2026F
Figure 9: North America Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 10: North America Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 11: North America Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 12: North America Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 13: North America Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 14: North America Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
Figure 15: United States Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 16: United States Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 17: United States Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 18: United States Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 19: United States Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 20: Canada Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 21: Canada Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 22: Canada Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 23: Canada Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 24: Canada Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 25: Mexico Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 26: Mexico Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 27: Mexico Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 28: Mexico Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 29: Mexico Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 30: Europe Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 31: Europe Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 32: Europe Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 33: Europe Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 34: Europe Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 35: Europe Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
Figure 36: Germany Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 37: Germany Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 38: Germany Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 39: Germany Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 40: Germany Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 41: United Kingdom Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 42: United Kingdom Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 43: United Kingdom Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 44: United Kingdom Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 45: United Kingdom Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 46: France Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 47: France Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 48: France Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 49: France Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 50: France Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 51: Italy Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 52: Italy Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 53: Italy Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 54: Italy Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 55: Italy Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 56: Spain Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 57: Spain Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 58: Spain Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 59: Spain Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 60: Spain Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 61: Asia Pacific Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 62: Asia Pacific Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 63: Asia Pacific Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 64: Asia Pacific Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 65: Asia Pacific Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 66: Asia Pacific Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
Figure 67: China Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 68: China Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 69: China Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 70: China Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 71: China Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 72: Japan Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 73: Japan Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 74: Japan Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 75: Japan Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 76: Japan Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 77: India Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 78: India Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 79: India Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 80: India Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 81: India Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 82: South Korea Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 83: South Korea Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 84: South Korea Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 85: South Korea Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 86: South Korea Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 87: Australia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 88: Australia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 89: Australia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 90: Australia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 91: Australia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 92: South America Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 93: South America Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 94: South America Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 95: South America Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 96: South America Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
Figure 97: Brazil Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 98: Brazil Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 99: Brazil Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 100: Brazil Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 101: Brazil Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 102: Argentina Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 103: Argentina Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 104: Argentina Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 105: Argentina Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 106: Argentina Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 107: Colombia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 108: Colombia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 109: Colombia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 110: Colombia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 111: Colombia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 112: Middle East & Africa Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 113: Middle East & Africa Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 114: Middle East & Africa Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 115: Middle East & Africa Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 116: Middle East & Africa Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 117: Middle East & Africa Infectious Disease Testing Market Share, By Country, By Value, 2016-2026F
Figure 118: South Africa Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 119: South Africa Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 120: South Africa Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 121: South Africa Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 122: South Africa Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 123: Saudi Arabia Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 124: Saudi Arabia Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 125: Saudi Arabia Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 126: Saudi Arabia Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 127: Saudi Arabia Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 128: UAE Infectious Disease Testing Market Size, By Value (USD Million), 2016-2026F
Figure 129: UAE Infectious Disease Testing Market Share, By Product and Service, By Value, 2016-2026F
Figure 130: UAE Infectious Disease Testing Market Share, By Technology, By Value, 2016-2026F
Figure 131: UAE Infectious Disease Testing Market Share, By Disease, By Value, 2016-2026F
Figure 132: UAE Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Meridian Bioscience Inc.
- Quidel Corporation
- Siemens AG
- Thermo Fisher Scientific Inc.
- Johnson and Johnson
- F. Hoffmann-La Roche Ltd
- Cepheid Inc.
- Qiagen N.V.
- OraSure Technologies, Inc.
![In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12002/12002788_60px_jpg/invitro_diagnostics_market.jpg)
